Alpha‐interferon as induction and maintenance therapy in hairy cell leukemia:a long‐term follow‐up analysis.

Autor: Damasio, E. E.¹, Clavio, M.¹, Masoudi, B.¹, Isaza, A.¹, Spriano, M.¹, Rossi, E.¹, Casciaro, S.¹, Cerri, R.¹, Risso, M.¹, Nati, S.¹, Siccardi, M.¹, Truini, M.², Gobbi, M.¹

Publikováno v: European Journal of Haematology. Jan2000, Vol. 64 Issue 1, p47-52. 6p.

Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)

Autor: Keating, S., Witte, T.J.M. de, Suciu, S., Mandelli, F., Damasio, E., Willemze, R., Morra, E., Amadori, S., Dardenne, M., Vegna, M.L., Zittoun, R.

Publikováno v: European Journal of Cancer, 35, 1440-7
European Journal of Cancer, 35, 10, pp. 1440-7

Item does not contain fulltext In the AML 8A study patients were treated with remission-induction therapy followed by one consolidation course. Patients in complete remission (CR) were randomised between autologous bone marrow transplantation (ABMT)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::14bb9b8bac8c29a2ff5891a23e61a630
https://hdl.handle.net/2066/185984

Will Molecular Biology Contribute to Refine Prognosis and to Select Treatment?

Autor: Zaccaria, A, Martinelli, G, Buzzi, M, Farabegoli, P, Saglio, G, Guerrasio, A, Bernabei, P, Santini, V, Pellicci, P, Mencarelli, A, Coco, F, Diverio, D, Rambaldi, A, Santoro, A, Tura, S, Russo, D, Zuffa, E, Fanin, R, Patriarca, F, Fiacchini, M, Baccarani, M, Testoni, N, Zamagni, M, Montefusco, E, Alimena, G, Meloni, G, Mandelli, F, Damiani, D, Michieli, M, Criscuolo, D, Fowst, C, Holdener, E, Specchia, G, Liso, V, Morra, E, Bernasconi, C, Demilio, A, Battista, R, Ditucci, A, Broccia, G, Maiolino, I, Caronia, F, Luciano, L, Rotoli, B, Leoni, P, Danieli, G, Bodenizza, C, Carotenuto, M, Rotondo, S, Nosari, A, Decataldo, F, Montuoro, A, Delaurenzi, A, Camillo, S, Liberati, A, Grignani, F, Tabilio, A, Martelli, M, Barbui, T, Leoni, F, Ciolli, S, Ronca, F, Nobile, F, Paolino, F, Resegotti, L, Papineschi, F, Spremolla, G, Landolfi, R, Leone, G, Volpe, E, Mangoni, L, Rizzoli, V, Capucci, A, Izzi, T, Scapoli, G, Castoldi, G, Gentilini, I, Coser, P, Gallo, E, Pileri, A, Cantonetti, M, Papa, G, Dini, D, Morandi, S, Bianchini, E, Pinotti, G, Venco, A, Zagonel, V, Pinto, A, Capaldi, A, Giovannelli, E, Pizzuti, M, Ricciuti, F, Ambrosetti, A, Cajozzo, A, Lombardo, M, Torlontano, G, Delfini, C, Lucarelli, G, Girino, M, Ascari, E, Risso, M, Damasio, E, Martino, S, Pardini, S, Longinotti, M, Miraglia, E, Debiase, R, Nardelli, S, Galieni, P, Dispensa, E, Abbadessa, A, Bruzzese, L, Prossomariti, L, Cimino, R, Derosa, C, Gabbas, A, Francesco, S, Gallamini, A, Difrancesco, A, Quaglino, D, Musolino, C, Squadrito, G, Avanzini, P, Gobbi, F, Nuova, A, Emilia, R, Aglietta, M, Camaschella, C, Mazza, M, Guglielmo, P, Cacciola, E, Monaco, M

Publikováno v: Leukemia & Lymphoma. 11:81-89

The possible prognostic value of the position of the breakpoint within the M-BCR in patients with Phl+ CML is still being debated. We analyzed the DNA rearrangements and the transcript types of 244 patients and tried to correlate the data obtained wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd81cfca223236b191198e9776e4285
https://doi.org/10.3109/10428199309047869

Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens

Autor: Clavio, M, Quintino, S, Masoudi, B, Carrara, S, Cerri, R, Pierri, Ivana, Canepa, L, Miglino, Maurizio, Muner, P, Damasio, E, Gobbi, Marco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3710::6cc452079f272752d5925c0d5ce19ca1
http://hdl.handle.net/11567/391230

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial

Autor: Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Giorgina Specchia, Caiozzo, A., Raimondi, R., Mandelli, F., Cascavilla, N., Rigolin, G., Deliliers, G. L., Martino, B., Peta, A., Ricci P., Fanci, R., Plano, W., Sivera, P., Zagonel, V., Caramatti, C., Invernizzi, R., Buelli, M., Bernasconi, C., Carella, A., Damasio, E., Biasi, R., Chierichini, A., Galieni, P., Grasso, M., Jacopino, P., Morra, E., Porcellini, A., Resegotti, L., Ricciuti, F., Picardi, M., Ronconi, F., Cimino, R., Ferrandina, C., Gabbas, A., Mettivier, V.

Publikováno v: Scopus-Elsevier

To evaluate the efficacy and safety of itraconazole oral solution for preventing fungal infections, a randomized, placebo-controlled, double-blind, multicenter trial was conducted: 405 neutropenic patients with hematologic malignancies were randomly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fc332118a91e28413bd542ad3b04dc
http://hdl.handle.net/11568/927159